GKOS
Glaukos Corporation · Healthcare
Chief Development Officer Tomas Navratil sold $243K of Glaukos Corporation
Sold$243,204
$166.92Price
1,457Shares
−2%Stake
What GKOS did after the filing
- The stock from Mon, Sep 21 open, $166.27
- +3.6%
- S&P 500, same days
- +1.4%
12 of 30 trading days so far, to the Oct 7 close.
Traded Wed, Sep 16. Filed Fri, Sep 18, 5:32 PM ET, after the close. Returns use the Sep 21 open and the Oct 7 close. Not investment advice.